col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


388 Results       Page 1

 [1] 
Wiley: Journal of the European Academy of Dermatology and Venereology
  original article Date Title Authors   All Authors
1 [GO] 2022―May―16 Impact of the Covid-19 pandemic on Melanoma and Non-melanoma skin cancer inpatient treatment in Germany - a nationwide analysis Johannes Kleemann, Markus Meissner, Deniz Özistanbullu, Ümniye Balaban, Oliver Old, Stefan Kippenberger, et al. (+4)
2 [GO] 2022―May―11 Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workers X. Lin, Y.Z. Li, T. Chen, S.H. Min, D.F. Wang, M.M. Ding, G. Jiang
3 [GO] 2022―May―10 Erythrodermic pityriasis rubra pilaris after SASRS-CoV-2 vaccination with concomitant COVID-19 infection T. Gambichler, C.H. Scheel, Y. Arafat, O. Kautz, S. Boms
4 [GO] 2022―May―10 A case of onychomadesis associated to chilblain-like lesions after COVID-19 infection Cristiana Colonna, Serena Giacalone, Martina Zussino, Nicola Adriano Monzani, Stefano Cambiaghi, Riccardo Cavalli
5 [GO] 2022―May―10 Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient Elena Gimeno, Daniel Morgado-Carrasco, David Moriscot, Jaime Piquero-Casals
6 [GO] 2022―May―10 Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event Michael Kasperkiewicz
7 [GO] 2022―May―10 Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine- a series of 37 cases Alpana Mohta, Manoj Kumar Sharma
8 [GO] 2022―May―10 Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination Alexander Kreuter, Sara Lausch, Sven-Niklas Burmann, Alexandros Paschos, Alena-Lioba Michalowitz
9 [GO] 2022―May―10 Allergic reaction to Red Cosmetic lip tattoo with possible exacerbations after SARS-CoV-2 vaccination Nicolas Kluger
10 [GO] 2022―Apr―26 Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley
11 [GO] 2022―Apr―26 Negative SARS-CoV -2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions E. Welsh, J. A. Cardenas-de la Garza, E. Brussolo-Marroquín, A. Cuellar-Barboza, R. Franco-Marquez, Gerardo Ramos-Montañez
12 [GO] 2022―Apr―16 Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire based study Jai Bawane, Rajesh Kataria, Anil Mohite, Kapila Verma, Utkarsh Shukla
13 [GO] 2022―Apr―16 Disseminated herpes zoster in an immune-competent patient after SARS-CoV -2 Vaccine ( BNT162b2 Comirnaty, Pfizer) Corrado Zengarini, Cosimo Misciali, Tiziano Ferrari, Emi Dika, Michelangelo La Placa, Bianca Maria Piraccini, Carlotta Baraldi
14 [GO] 2022―Apr―16 SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption Dillon Mintoff, David Pisani, Nevise Livori, Ian Said-Huntingford, Godfrey Baldacchino
15 [GO] 2022―Apr―10 Hemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination Yi-Teng Hung, Wen-Hung Chung, Tsung-Fu Tsai, Chun-Bing Chen
16 [GO] 2022―Mar―30 Commentary on “Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine” Dursun Turkmen, Nihal Altunisik
17 [GO] 2022―Mar―30 Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series A. Lepekhova, E. Grekova, O. Olisova, E. Dunaeva, S. Ahmed, I. Maximov, N. Teplyuk
18 [GO] 2022―Mar―30 A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms A. Aoki, M. Yamane, Y. Aoyama
19 [GO] 2022―Mar―29 De novo annular pustular psoriasis following mRNA COVID-19 vaccine M. Romagnuolo, P. Pontini, S. Muratori, A. V. Marzano, C. Moltrasio
20 [GO] 2022―Mar―28 Symmetrical drug-related intertriginous and flexural exanthema like eruption after COVID-19 vaccine Ines Lahouel, Nesrine Ben Salah, Najeh Ben Fadhel, Ferdaous Chahed, Nourelimene Ouni, Hichem Belhadjali, et al. (+2)
21 [GO] 2022―Mar―19 Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthem Andrea Sechi, Andrea Bassi, Carlo Mazzatenta, Mario Cutrone, Luigi Naldi, Giuseppe Argenziano, Vincenzo Piccolo
22 [GO] 2022―Mar―19 Transient inflammation in surgical scars following Covid-19 mRNA vaccination C. Ferreli, J. Anedda, L. Atzori L
23 [GO] 2022―Mar―12 Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic L.F. Kiely, C. O'Connor, G. O’Briain, C. O’Briain, J. Gallagher, J.F. Bourke
24 [GO] 2022―Mar―12 Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin P.R. Criado, M. Ianhez, P.S. Rocha, H.A. Miot
25 [GO] 2022―Mar―12 Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence? L. Sun, S. Duarte, L. Soares-de-Almeida
26 [GO] 2022―Mar―12 Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco H. Kerrouch, M. Khalidi, R. Frikh, N. Hjira, M. Boui
27 [GO] 2022―Mar―12 Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy S. Caini, M. Brusasco, G. Niero, V. De Giorgi, M. Lombardo, C. Massone, et al. (+8)
28 [GO] 2022―Mar―11 Erythema Multiforme in COVID-19 Patients and Following COVID-19 Vaccination: Manifestations, Associations, and Outcomes Farshid Etaee, Mohamadmehdi Eftekharian, Tarek Naguib, Steven Daveluy
29 [GO] 2022―Mar―11 Prevalence and patterns of cutaneous manifestations in 1,245 COVID-19 patients in Japan: a single-centre study T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
30 [GO] 2022―Mar―11 Another case of generalized bullous fixed drug eruption following an adenoviral-vector based Covid-19 vaccine (ChAdOx1 nCov-19) Chaker Ben Salem, Abdelmajid Khelif, Dhouha Sahnoun, Nadia Ghariani, Badreddine Sriha, Mohamed Denguezli
31 [GO] 2022―Mar―11 Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination A Yoshida, T Ikegami, K Igawa
32 [GO] 2022―Feb―28 Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab G. Pavia, L. Gargiulo, F. Spinelli, J. Avagliano, M. Valenti, R. G. Borroni, et al. (+2)
33 [GO] 2022―Feb―28 Erythema Nodosum Leprosum Post-COVID-19 Vaccination: Endemic while Pandemic Tahel Fachler, Karen Olshtain-Pops, Liran Horev
34 [GO] 2022―Feb―27 Association between vaccination and immunobullous disorders: A brief, updated systematic review with focus on COVID-19 Michael Kasperkiewicz, David T. Woodley
35 [GO] 2022―Feb―20 Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination Tuomas Mäkilä, Leila Jeskanen, Mariia Butina, Liisa Harjama, Annamari Ranki, Tarja Mälkönen, Nicolas Kluger
36 [GO] 2022―Feb―17 A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine Shin-ichiro Ohmura, Shiho Hanai, Ryuhei Ishihara, Yusuke Ohkubo, Toshiaki Miyamoto
37 [GO] 2022―Feb―17 Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic Federico Bardazzi, Lidia Sacchelli, Camilla Loi, Federica Filippi, Alba Guglielmo
38 [GO] 2022―Feb―17 Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia Yi-Teng Hung, Yen-Lin Huang, Yao-Yu Chang, Wei-Ti Chen
39 [GO] 2022―Feb―08 Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccine C. Aimo, E.B. Mariotti, A. Corrà, E. Cipollini, O. Le Rose, C. Serravalle, et al. (+2)
40 [GO] 2022―Jan―29 The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays E. Slotman, K. Schreuder, T.E.C. Nijsten, M. Wakkee, L. Hollestein, A. Mooyaart, et al. (+2)
41 [GO] 2022―Jan―26 Estimating the incidence of Covid-19 skin manifestations on the general population in a territorial setting Corrado Zengarini, Alba Guglielmo, Matteo Giovani, Cecilia Preci, Emi Dika, Bianca Maria Piraccini, Alessandro Pileri
42 [GO] 2022―Jan―25 Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander C. Katoulis, Ioanna Gkiaouraki, Kyriaki Zografaki, et al. (+2)
43 [GO] 2022―Jan―24 Eruptive pyogenic granulomas following COVID-19. Carlo Alberto Maronese, Chiara Moltrasio, Dario Antonio Marletta, Giovanni Genovese, Angelo Valerio Marzano
44 [GO] 2022―Jan―24 Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients L. Potestio, M. Napolitano, L. Bennardo, G. Fabbrocini, C. Patruno
45 [GO] 2022―Jan―24 A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India S Arora, G K Singh, P Das, R Rahman, P Bellad, R Shrivastav, et al. (+3)
46 [GO] 2022―Jan―24 Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al. G Avallone, S Giordano, C Astrua, M Merli, R Senetta, C Conforti, et al. (+3)
47 [GO] 2022―Jan―24 Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination W.-K. Hung, C.-C. Chi
48 [GO] 2022―Jan―23 Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination T. Ogawa, U. Aitake, T. Nomura
49 [GO] 2022―Jan―23 A first case of “Covid toes” from a viral vector-based COVID-19 vaccine A. Van Loon, D. Mortelmans, V. Siozopoulou, B. Ogunjimi, H. Jansens, J. Lambert, O. Aerts
50 [GO] 2022―Jan―16 Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists P. Gisondi, F. Bellinato, G. Girolomoni
51 [GO] 2022―Jan―12 Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine Jerome Kaikati, Antoine Ghanem, Reem El Bahtimi, Josiane Helou, Roland Tomb
52 [GO] 2022―Jan―11 Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature Gaetano Licata, Dario Buononato, Carmine Fiorentino, Giulia Calabrese, Alina De Rosa, Giuseppe Argenziano, Alessio Gambardella
53 [GO] 2022―Jan―11 Pityriasis lichenoides et varioliformis acuta following COVID-19 mRNA vaccination J Palmén, M Lepistö, L Talve, N Hieta
54 [GO] 2022―Jan―11 Wells’ syndrome following Oxford-AstraZeneca COVID-19 vaccination Yulhee Kim, You Chan Kim
55 [GO] 2022―Jan―11 Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination Anil Kumar Panda, Farheen Begum, Maitreyee Panda, Ajaya Kumar Jena
56 [GO] 2021―Dec―22 Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19) Clémence Masseran, Andreea Cӑlugӑreanu, Frédéric Caux, Gérôme Bohelay
57 [GO] 2021―Dec―21 Telemedicine and Dermatology Hospital Consultations During The COVID-19 Pandemic: A Multi-Center Observational Study on Resource Utilization and Conversion to In-Person Consultations During the COVID-19 Pandemic John Trinidad, Colleen K Gabel, Lauren Bonomo, Alexander Cartron, Sidharth Chand, William Coburn, et al. (+40)
58 [GO] 2021―Dec―20 Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review Michele Pauluzzi, Giuseppe Stinco, Enzo Errichetti
59 [GO] 2021―Dec―20 SCLE manifestation after mRNA COVID-19 vaccination Laura Rechtien, Cornelia Erfurt-Berge, Michael Sticherling
60 [GO] 2021―Dec―20 Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort E. Massip, P. Marcant, G. Font, S. Faiz, S. Duvert-Lehembre, I. Alcaraz, et al. (+7)
61 [GO] 2021―Dec―20 High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection. Baptiste Mille, Saskia Ingen-Housz-Oro, Nicolas De Prost, Guillaume Voiriot, Angèle Soria, Florence Tetart, et al. (+4)
62 [GO] 2021―Dec―20 Primitive melanoma and COVID 19 are we still paying the price of the pandemic? F. Ricci, G. Di Lella, L. Fania, F. Ricci, L. Sobrino, S. Pallotta, et al. (+3)
63 [GO] 2021―Dec―16 Exuberant lichenoid eruption after Oxford-AstraZeneca COVID-19 vaccine: a singular case C. Correia, S. Fernandes, L. Soares-de-Almeida, P. Filipe
64 [GO] 2021―Dec―12 Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae Alin Laurentiu Tatu, Thomas Nadasdy, LC Nwabudike
65 [GO] 2021―Dec―12 Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al. E Camela, G Guerrasio, C Patruno, M Scalvenzi, N Di Caprio, G Fabbrocini, M Napolitano
66 [GO] 2021―Dec―12 Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient G Knechtl, SM Seyed Jafari, T Berger, A Rammlmai, L Feldmeye, L Borradori
67 [GO] 2021―Dec―04 Trend of sexually transmitted infections during the Covid-19 age. Which was the impact of the pandemic and the social distancing measures? L. Ronga, S. Stolfa, F. Romanelli, D.F. Bavaro, A. Saracino, A. Mosca, et al. (+6)
68 [GO] 2021―Dec―04 Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant A. Giannattasio, M. Rosa, S. Esposito, O. Di Mita, F. Angrisani, S. Acierno, et al. (+4)
69 [GO] 2021―Nov―28 Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination Ai Kuzumi, Ayumi Yoshizaki, Kazue Chiba, Shunki Mitsuo, Kazuki M Matsuda, Yuta Norimatsu, et al. (+4)
70 [GO] 2021―Nov―28 Pityrosporum folliculitis in critically ill COVID-19 patients Fernanda Lagares Xavier Peres, Renan Rangel Bonamigo, Gustavo Borchardt Bottega, Fernanda Luiza Staub, André da Silva Cartell, Bakos Marchiori Renato
71 [GO] 2021―Nov―28 Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle Kaushiki Hajra, Uddalak Chakraborty, Kingshuk Chatterjee, Atanu Chandra, Saswati Halder
72 [GO] 2021―Nov―22 COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases A. Tammaro, D. Karim, G. A. R. Adebanjo, F. R. Parisella, C. Chello, A. F. Salih, J. Rello
73 [GO] 2021―Nov―22 Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, et al. (+3)
74 [GO] 2021―Nov―22 Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitis Corrado Zengarini, Alessandro Pileri, Francesco Paolo Salamone, Bianca Maria Piraccini, Giovanni Vitale, Michelangelo La Placa
75 [GO] 2021―Nov―13 Another year in the grip of COVID-19 with slow recovery J. Ring
76 [GO] 2021―Nov―10 Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity R. Molinier, A. Roger, B. Genet, A. Blom, C. Longvert, L. Chaplain, et al. (+3)
77 [GO] 2021―Nov―10 Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination Elisa Cinotti, Jean-Luc Perrot, Francesco Bruzziches, Linda Tognetti, Anastasia Batsikosta, Ester Sorrentino, et al. (+2)
78 [GO] 2021―Nov―10 Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children I. Proietti, E. Tolino, A. Mambrin, N. Skroza, N. Bernardini, A. Marchesiello, et al. (+7)
79 [GO] 2021―Nov―10 Dermatologic emergency unit, day-care hospital and consultations in time of COVID-19: the impact of teledermatology Alice Brehon, Jason Shourick, Camille Hua, Charbel Skayem, Pierre Wolkenstein, Olivier Chosidow, Tu Anh Duong
80 [GO] 2021―Nov―09 At-risk circumstances for COVID-19 increase the risk of pruritus: cross-sectional and longitudinal analyses T. Kogame, Y. Ogawa, K. Kabashima, Y. Yamamoto
81 [GO] 2021―Nov―09 Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption A. Sernicola, A. Dybala, V. Gomes, P. Maddalena, F. Adotti, G. Soda, et al. (+4)
82 [GO] 2021―Oct―26 Regression of common viral warts after ChAdOx1-S COVID-19 vaccine Anna Płaszczyńska, Martyna Sławińska, Michał Sobjanek
83 [GO] 2021―Oct―20 Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine N. Cameli, M. Silvestri, M. Mariano, L. Bennardo, S.P. Nisticò, A. Cristaudo
84 [GO] 2021―Oct―19 Incidence and Prognosis of COVID-19 in Patients with Psoriasis on Apremilast: A Multicenter Retrospective Cohort Study Yuliya Lytvyn, Jorge R Georgakopoulos, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, Vipul Jain, et al. (+4)
85 [GO] 2021―Oct―19 Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2? Cristina Moya-Martinez, Emilio de Dios Berná-Rico, Ana Melian-Olivera, Carmen Moreno-Garcia del Real, Diego Fernández-Nieto
86 [GO] 2021―Oct―19 Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workers Pawinee Rerknimitr, Thanaporn Puaratanaarunkon, Chanidapa Wongtada, Namthong Wittayabusarakam, Saran Krithin, Leilani Paitoonpong, et al. (+5)
87 [GO] 2021―Oct―19 Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine C Kouki, K Sellami, E Bahloul, M Amouri, A Masmoudi, H Turki
88 [GO] 2021―Oct―19 Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech) Minjae Kim, Jee Woo Kim, Minsu Kim, Sun Young Choi, Jung-Im Na
89 [GO] 2021―Oct―19 Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma Manon Blaise, Fanny Rocher, Hélène Spittler, Adrien Sanchez, Elisabeth Lanteri, Lucia Coco, et al. (+5)
90 [GO] 2021―Oct―19 Cutaneous findings following COVID-19 vaccination: review of world literature and own experience T. Gambichler, S. Boms, L. Susok, H. Dickel, C. Finis, N. Abu Rached, et al. (+3)
91 [GO] 2021―Oct―10 Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccination E Panou, V Nikolaou, L Marinos, S Kallambou, P Sidiropoulou, M Gerochristou, A Stratigos
92 [GO] 2021―Oct―05 Herpes Zoster Viral (HZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: a case series. Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander Katoulis, Vasiliki Koumaki, George Evangelou, et al. (+4)
93 [GO] 2021―Oct―05 SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone Syed M. A. Ahmed, Martina Volontè, Eugenio Isoletta, Camilla Vassallo, Carlo Francesco Tomasini, Daniele Lilleri, et al. (+4)
94 [GO] 2021―Oct―05 Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer) Corrado Zengarini, Cosimo Misciali, Tiziana Lazzarotto, Emi Dika
95 [GO] 2021―Sep―21 Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis V. Sánchez-García, R. Hernández-Quiles, E. de-Miguel-Balsa, A. Docampo-Simón, I. Belinchón-Romero, J.M. Ramos-Rincón
96 [GO] 2021―Sep―21 Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type? S Cretu, M Dascalu, SR Georgescu, CM Salavastru
97 [GO] 2021―Sep―21 Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine Laurence Montjoye, Liliane Marot, Marie Baeck
98 [GO] 2021―Sep―21 Early atypical injection-site reactions to COVID-19 vaccine: a case series M. Vaccaro, L. Bertino, R. Squeri, C. Genovese, S. Isola, G. Spatari, et al. (+2)
99 [GO] 2021―Sep―21 Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India Hitaishi Mehta, Sanjeev Handa, Pankaj Malhotra, Meenakshi Patial, Smriti Gupta, Anirudh Mukherjee, et al. (+3)
100 [GO] 2021―Sep―21 New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? David Pesqué, Emilio Lopez-Trujillo, Orianna Marcantonio, Ana Maria Giménez-Arnau, Ramon Maria Pujol
101 [GO] 2021―Sep―21 A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine J. Young, L. Mercieca, M. Ceci, D. Pisani, A. Betts, M.J. Boffa
102 [GO] 2021―Sep―21 SARS-CoV-2 mRNA Vaccine Injection Site Pseudolymphoma Dillon Mintoff, Lawrence Scerri, Alexandra Betts
103 [GO] 2021―Sep―21 Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema Multiforme Luca Borg, Liam Mercieca, Dillon Mintoff, Daniel Micallef, David Pisani, Alexandra Betts, Lawrence Scerri
104 [GO] 2021―Sep―21 Erythema multiforme after SARS-CoV-2 vaccine Li-wen Zhang, Wen-ju Wang, Cong-hui Li, Tao Chen
105 [GO] 2021―Sep―21 Nevocentric erythema multiforme after SARS-COV-2 Vaccine C. Scharf, E. V. Brizzi, S. Pellerone, M. Liguori, C.M.R. Giorgio, G. Argenziano
106 [GO] 2021―Sep―17 Reply to “Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center” by Sotiriou E et al. M. Megna, L. Potestio, L. Gallo, G. Caiazzo, A. Ruggiero, G. Fabbrocini
107 [GO] 2021―Sep―07 Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine Linting Huang, Zhirong Yao, Jia Zhang
108 [GO] 2021―Sep―06 COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo, and chronic urticaria P.R. Criado, M. Ianhez, C.C. Silva de Castro, C. Talhari, P.M. Ramos, H.A. Miot
109 [GO] 2021―Sep―06 Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak EJ Chun, JK Kim, SY Yang, SS Kim, CW Kim
110 [GO] 2021―Sep―06 Erythema annulare centrifugum triggered by SARS-CoV-2 infection N Setó-Torrent, A Altemir, M Iglesias-Sancho, MT Fernández-Figueras
111 [GO] 2021―Aug―30 Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines M. Tihy, S. Menzinger, R. André, E. Laffitte, L. Toutous-Trellu, G. Kaya
112 [GO] 2021―Aug―21 The crucial role of clinicopathological correlation in COVID-19-related cutaneous manifestations F. Rongioletti
113 [GO] 2021―Aug―20 SARS-CoV-2 in the sweat of COVID-19 positive patients: a possible route of transmission? S. Recalcati, S. Tonolo, E. Meroni, F. Fantini
114 [GO] 2021―Aug―20 Flagellate Purpura Associated With COVID-19 Vaccination Emma Heck, Brian D. Rankin, Michelle Schneider, Vimal H. Prajapati
115 [GO] 2021―Aug―20 Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations G Ciccarese, F Drago, A Rebora, A Parodi
116 [GO] 2021―Aug―09 Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single center Elçin Akdaş, Betül Öğüt, Özlem Erdem, Murat Orhan Öztaş, Nilsel İlter
117 [GO] 2021―Aug―07 Erythema Gyratum Repens after COVID-19 R Castro Silva, G Castro Silva, MC Castro Silva, O Lupi
118 [GO] 2021―Aug―07 Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19 Chenyang Huang, Qingmiao Sun, Daixi Jiang, Xiaobao Zhang, Can Chen, Danying Yan, et al. (+9)
119 [GO] 2021―Aug―07 Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center E Sotiriou, A Tsentemeidou, K Bakirtzi, A Lallas, D Ioannides, E Vakirlis
120 [GO] 2021―Aug―07 Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine) Lester Juay, Nisha Suyien Chandran
121 [GO] 2021―Aug―07 Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature E. Annabi, N. Dupin, P. Sohier, B. Garel, N. Franck, S. Aractingi, et al. (+2)
122 [GO] 2021―Aug―07 Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: A case series from the Philippines J.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete
123 [GO] 2021―Aug―07 Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults Ahmet Kağan Özdemir, Sera Kayhan, Seray Külcü Çakmak
124 [GO] 2021―Aug―07 Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series Maria Vastarella, Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini
125 [GO] 2021―Jul―26 Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19) P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, et al. (+3)
126 [GO] 2021―Jul―26 Dermatoses caused by face mask wearing during the COVID-19 pandemic Olga Yu. Olisova, Natalia P. Teplyuk, Ekaterina V. Grekova, Anfisa A. Lepekhova
127 [GO] 2021―Jul―26 The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities Clio Dessinioti, Claus Garbe, Alexander J Stratigos
128 [GO] 2021―Jul―26 New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report M. Lehmann, P. Schorno, R. E. Hunger, K. Heidemeyer, L. Feldmeyer
129 [GO] 2021―Jul―26 Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine A. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller
130 [GO] 2021―Jul―26 A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine R. Pasternack, S. Pohjavaara
131 [GO] 2021―Jul―26 Small vessel vasculitis related to varicella zoster virus after Pfizer-BioNTech COVID-19 vaccine Francesca Nastro, Gabriella Fabbrocini, Francesca di Vico, Claudio Marasca
132 [GO] 2021―Jul―26 Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila
133 [GO] 2021―Jul―26 Small vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 Luisa Guzmán-Pérez, Mario Puerta-Peña, Daniel Falkenhain-López, Julia Montero-Menárguez, Christian Gutiérrez-Collar, José Luis Rodríguez-Peralto, Jimena Sanz-Bueno
134 [GO] 2021―Jul―26 Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection M. Brito Caldeira, M. Pestana, A. Luísa João, C. Fernandes, A. João, N. Cunha
135 [GO] 2021―Jul―26 Herpes Zoster following SARS-CoV-2 vaccination - a series of 4 cases M Alpalhão, P Filipe
136 [GO] 2021―Jul―26 New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: Clinical images and histopathological study of 3 cases D. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto
137 [GO] 2021―Jul―23 Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
138 [GO] 2021―Jul―14 Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa, Consuelo Cárdenas, Juan Camilo Castro, et al. (+13)
139 [GO] 2021―Jul―09 Transition of cutaneous into systemic lupus erythematosus following adenoviral vector based SARS-CoV-2 vaccination Alexander Kreuter, Sven-Niklas Burmann, Björn Burckert, Frank Oellig, Alena-Lioba Michalowitz
140 [GO] 2021―Jul―09 “COVID arm” - histological features of a delayed type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine W. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz
141 [GO] 2021―Jul―08 Development of eruptive pseudoangiomatosis following COVID-19 immunization- apropos of 5 cases Alpana Mohta, Suresh Kumar Jain, Rajesh Dutt Mehta, Aakanksha Arora
142 [GO] 2021―Jul―08 Pityriasis rosea developing after COVID-19 vaccination O. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra
143 [GO] 2021―Jul―08 New-onset cutaneous lichen planus triggered by COVID-19 vaccination R. Merhy, A.S Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan
144 [GO] 2021―Jul―08 Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine AC Leasure, S Cowper, J McNiff, JM Cohen
145 [GO] 2021―Jul―08 Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine N. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo
146 [GO] 2021―Jul―08 New onset of Remitting Seronegative Symmetrical Synovitis with Pitting Oedema and Palmoplantar Psoriasis flare-up after Sars-Cov-2 Vaccination L Quattrini, L Verardi, G Caldarola, G Peluso, C De Simone, M D’Agostino
147 [GO] 2021―Jul―08 Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine. D Falkenhain-López, C Gutiérrez-Collar, J Arroyo-Andrés, I Gallego-Gutiérrez, JL Rodríguez-Peralto, A Sánchez-Velázquez
148 [GO] 2021―Jun―25 The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? Giovanni Damiani, Alessia Pacifico, Francesco Pelloni, Matilde Iorizzo
149 [GO] 2021―Jun―25 Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 Farzan Solimani, Yasmine Mansour, Dario Didona, Amrei Dilling, Kamran Ghoreschi, Katharina Meier
150 [GO] 2021―Jun―24 Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? Jeong Eun Kim, Hyun Lee, Seung Sam Paik, Ji-Yong Moon, Ho Joo Yoon, Sang-Heon Kim
151 [GO] 2021―Jun―19 Evolution of notified sexually transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic Gemma Martin-Ezquerra, Pablo Monreal, Lilas Mercuriali, Esperanza Cañas-Ruano, Ramon M Pujol, Xavier Duran, et al. (+28)
152 [GO] 2021―Jun―19 The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K Gabel, Sarah Song, Zachary Holcomb, et al. (+9)
153 [GO] 2021―Jun―18 Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, et al. (+31)
154 [GO] 2021―Jun―16 Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine PK Krajewski, Ł Matusiak, JC Szepietowski
155 [GO] 2021―Jun―16 Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 C. Lesort, J. Kanitakis, L. Donzier, D. Jullien
156 [GO] 2021―Jun―16 A review of nail findings associated with COVID-19 infection Edward Hadeler, Brian W. Morrison, Antonella Tosti
157 [GO] 2021―Jun―16 Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in Korea S.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, et al. (+2)
158 [GO] 2021―Jun―03 Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
159 [GO] 2021―Jun―02 Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, et al. (+26)
160 [GO] 2021―Jun―02 Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine PK Krajewski, JC Szepietowski
161 [GO] 2021―May―31 Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine Ioannis Tessas, Nicolas Kluger
162 [GO] 2021―May―31 Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features. D. Kadylak, W. Barańska-Rybak
163 [GO] 2021―May―28 Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi
164 [GO] 2021―May―26 Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, et al. (+6)
165 [GO] 2021―May―26 Dapsone induced methemoglobinemia in leprosy: A close mimic of ‘happy hypoxia’ in the COVID-19 pandemic Tanu Tripathi, Anchit Raj Singh, Rajan Kapoor, Anwita Sinha, Saikat Ghosh, Kanwaljit Kaur, et al. (+4)
166 [GO] 2021―May―26 SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri
167 [GO] 2021―May―25 Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany
168 [GO] 2021―May―22 Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, et al. (+9)
169 [GO] 2021―May―20 Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology Laura Giraud-Kerleroux, Margaux Mongereau, Charles Cassius, Marc Mrad, Charlotte Gary, Caroline Fiani, et al. (+9)
170 [GO] 2021―May―20 Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, et al. (+8)
171 [GO] 2021―May―20 SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations B Cribier, C Taieb, M Saint Aroman, J Shourick
172 [GO] 2021―May―14 Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19 Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu
173 [GO] 2021―May―13 Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh
174 [GO] 2021―May―13 Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine M Gyldenløve, L Skov, CB Hansen, P Garred
175 [GO] 2021―May―13 Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen
176 [GO] 2021―Apr―29 Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19 C.C. Zouboulis, J.A.M. Laar, M. Schirmer, G. Emmi, F. Fortune, A. Gül, et al. (+5)
177 [GO] 2021―Apr―29 Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology R Guelimi, R Salle, L Dousset, H Assier, S Fourati, Z Bhujoo, et al. (+18)
178 [GO] 2021―Apr―29 Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report Elçin Akdaş, Nilsel İlter, Betül Öğüt, Özlem Erdem
179 [GO] 2021―Apr―29 BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, et al. (+2)
180 [GO] 2021―Apr―26 “Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance” JM Busto-Leis, G Servera-Negre, A Mayor-Ibarguren, E Sendagorta-Cudós, M Feito-Rodríguez, A Nuño-González, et al. (+2)
181 [GO] 2021―Apr―20 Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Vimal H. Prajapati, Jensen Yeung
182 [GO] 2021―Apr―19 Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis A Polat Ekinci, N Büyükbabani, S Meşe, G Pehlivan, NG Okumuş, A Ağaçfidan, E Özkaya
183 [GO] 2021―Apr―19 Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? S Signa, AR Sementa, MC Coccia, C Pastorino, G Viglizzo, S Viola, et al. (+7)
184 [GO] 2021―Apr―18 Adverse skin reactions related to PPE among health care workers managing COVID-19 Priyanka Sharma, Nainika Goel, Kanika Dogar, Mala Bhalla, GP Thami, Kavita Punia
185 [GO] 2021―Apr―18 Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? C Cassius, L Frumholtz, A de Masson, O Dadzie, A Petit
186 [GO] 2021―Apr―18 Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned? P. Sarkis, J. Sarkis, M. Alkassis, J. Assaf, K. El Gharib
187 [GO] 2021―Apr―09 Good tolerance of hyaluronic acid injections during the period of the Covid-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study Michael Naouri, Serge Dahan, Anne Le Pillouer Prost, Phrynée Coutant-Foulc, Catherine Raimbault, Françoise Cucurella, et al. (+10)
188 [GO] 2021―Apr―09 Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single centre case series M. Corbeddu, A. Diociaiuti, MR. Vinci, A. Santoro, V. Camisa, S. Zaffina, M. El Hachem
189 [GO] 2021―Apr―08 Nail changes as manifestation of systemic disease in COVID-19 infection SS Ocampo-Garza, J Ocampo-Candiani, E Camela, M Vastarella, G Fabbrocini, M Scalvenzi, A Villani
190 [GO] 2021―Mar―30 Extraordinary Claims Without Extraordinary Evidence Controversy on Anti-Androgen Therapy for COVID-19 R.M. Trüeb, A. Régnier, N. Caballero-Uribe, M.F. Reis Gavazzoni Dias, H. Dutra Rezende
191 [GO] 2021―Mar―30 Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine. M Ackerman, D Henry, A Finon, R Binois, E Esteve
192 [GO] 2021―Mar―30 Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization D. Fernandez-Nieto, J. Hammerle, M. Fernandez-Escribano, CM Moreno-del Real, P. Garcia-Abellas, I. Carretero-Barrio, et al. (+5)
193 [GO] 2021―Mar―29 Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19 M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, et al. (+4)
194 [GO] 2021―Mar―29 A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond? A Lowe, A Pararajasingam, FM Ali, S Dawood, CD Lowe, NM Stone
195 [GO] 2021―Mar―29 VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know F. Diotallevi, A. Campanati, G. Radi, E. Martina, G. Rizzetto, P Barbadoro, et al. (+2)
196 [GO] 2021―Mar―22 Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts J Ring, M Worm, A Wollenberg, JP Thyssen, T Jakob, L Klimek, et al. (+30)
197 [GO] 2021―Mar―17 Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity A García-Irigoyen, GA Acatitla-Acevedo, A Barrera-Godínez, S Méndez-Flores, J Domínguez-Cherit
198 [GO] 2021―Mar―16 COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation M. Kasperkiewicz, M. Yale, R. Strong, D. Zillikens, D.T. Woodley, A. Recke
199 [GO] 2021―Mar―16 Periocular capillaritis in a COVID-19 positive patient: report of a case A Paganelli, F Garbarino, L Bigi
200 [GO] 2021―Mar―16 Lichen planus arising after COVID-19 vaccination I. Hiltun, J. Sarriugarte, I. Martínez-de-Espronceda, A. Garcés, C. Llanos, R. Vives, J.I. Yanguas
201 [GO] 2021―Mar―16 Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination T. Gambichler, L. Scholl, L. Ocker, R. Stranzenbach
202 [GO] 2021―Mar―03 Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, et al. (+4)
203 [GO] 2021―Mar―02 Association Between COVID-19 and Chilblains: A Case-Control Study Daniel Ortega-Quijano, Diego Fernandez-Nieto, Juan Jimenez-Cauhe, Jose Luis Cortes-Cuevas, Daniel Marcos-Mencia, Mario Rodriguez-Dominguez, et al. (+3)
204 [GO] 2021―Mar―02 Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments P Gisondi, D Geat, L Naldi, S Piaserico
205 [GO] 2021―Mar―02 Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals Iria Neri, Francesca Conti, Annalucia Virdi, Alba Guglielmo, Lucia Leonardi, Ilaria Corsini, et al. (+6)
206 [GO] 2021―Feb―18 European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics Jacob P. Thyssen, Christian Vestergaard, Sebastien Barbarot, Marjolein S. de Bruin-Weller, Thomas Bieber, Alain Taieb, et al. (+29)
207 [GO] 2021―Feb―15 Relapse of chilblain-like lesions during the second wave of COVID-19 S. Recalcati, T. Barbagallo, S. Tonolo, M. Milani, F. Fantini
208 [GO] 2021―Feb―15 COVID-19 and immune checkpoint inhibitors M.S. Ahmed, H. Brehme, S. Friedrich, L. Reinhardt, S. Blum, S. Beissert, F. Meier
209 [GO] 2021―Feb―15 An Irish Department of Genito-Urinary Medicine in the COVID-19 Era D. Moriarty, C O’Connor, J. Bourke, M Murphy, M. Horgan, S Cremin
210 [GO] 2021―Feb―15 Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation G.C. Gondo, S.J. Bell, J. Slayden, G. Ullmann, A. Blauvelt
211 [GO] 2021―Feb―15 Rapidly progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib S. Berbert Ferreira, M.F.R. Gavazzoni Dias, R. Berbert Ferreira, A.C. Neves Neto, R.M. Trüeb, O. Lupi
212 [GO] 2021―Feb―15 Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? S. Piaserico, P. Gisondi, S. Cazzaniga, G. Girolomoni, PG. Calzavara-Pinton, L. Naldi
213 [GO] 2021―Feb―06 Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR MF García-Gil, J Monte-Serrano, M García García, Lucia Prieto-Torres, AJ Pascual-del-Riquelme, I Casas Flecha, M Ara-Martín
214 [GO] 2021―Feb―06 Chilblain-like lesions and COVID-19: second wave, second outbreak Vincenzo Piccolo, Andrea Bassi, Teresa Russo, Carlo Mazzatenta, Maura Baraldi, Giuseppe Argenziano, et al. (+2)
215 [GO] 2021―Feb―06 Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond J. Beecker, K.A. Papp, J. Dutz, R.B. Vender, R. Gniadecki, C. Cooper, et al. (+8)
216 [GO] 2021―Jan―18 COVID-19 and HHV8 first spotted together: an affair under electron microscopy E. Leoni, M. Cerati, G. Finzi, M. Lombardo, F. Sessa
217 [GO] 2021―Jan―15 Dermato-venereology in the year of coronavirus - Hot topics in research and patient care J. Ring
218 [GO] 2020―Dec―23 COVID-19 has changed our society as well as Dermatology J. Ring
219 [GO] 2020―Dec―23 Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines E. Papadavid, J. Scaribrick, P. Ortiz Romero, P. Quaglino, M. Vermeer, R. Knobler, et al. (+2)
220 [GO] 2020―Dec―18 Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic Karan Pandher, Caroline L. Porter, Hiral S. Patel, William W. Huang, Steven R. Feldman
221 [GO] 2020―Dec―09 Palmoplantar erythrodysestesia: a diagnostic sign of COVID-19 Almudena Nuno-Gonzalez, Kyrylo Magaletsky, Marta Feito Rodríguez, Ander Mayor Ibarguren, Maria Jose Beato, Elena Ruiz Bravo, Pedro Herranz Pinto
222 [GO] 2020―Dec―01 Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study. D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, J. Jimenez-Cauhe, P. Jaen-Olasolo, M. Fernandez-Guarino
223 [GO] 2020―Dec―01 Pityriasis rosea as a leading manifestation of COVID-19 infection R. Merhy, A.S Sarkis, F. Stephan
224 [GO] 2020―Nov―21 Adverse skin reactions following different types of mask usage during the COVID-19 pandemic Chayada Chaiyabutr, Thanisorn Sukakul, Chutipon Pruksaeakanan, Janista Thumrongtharadol Waranya Boonchai
225 [GO] 2020―Nov―21 Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China Yamin Zhang, Jingjing Wen, Mahin Alamgir, Jun Xie, Haixia Jing, Muping Fang, et al. (+5)
226 [GO] 2020―Nov―21 SARS-CoV-2-induced telogen effluvium: a multicentric study O.M. Moreno-Arrones, A. Lobato-Berezo, A. Gomez-Zubiaur, S. Arias-Santiago, D. Saceda-Corralo, C. Bernardez-Guerra, et al. (+9)
227 [GO] 2020―Nov―02 Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients Hélio Amante Miot, Mayra Ianhez, Paulo Müller Ramos
228 [GO] 2020―Nov―02 5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia John McCoy, Flávio Adsuara Cadegiani, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Natasha Atanaskova Mesinkovska, et al. (+5)
229 [GO] 2020―Nov―01 COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data L.E.M. de Wijs, M.M. Joustra, J.I. Olydam, T. Nijsten, D.J. Hijnen
230 [GO] 2020―Oct―22 Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 FA Cadegiani, RK Lim, A Goren, J McCoy, M Situm, M Kovacevic, et al. (+4)
231 [GO] 2020―Oct―22 Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? A. Diociaiuti, S. Giancristoforo, S. Terreri, M. Corbeddu, C. Concato, M. Ciofi Degli Atti, et al. (+3)
232 [GO] 2020―Oct―20 A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic K. Hansel, A. Zangrilli, L. Bianchi, K. Peris, A. Chiricozzi, A. Offidani, et al. (+7)
233 [GO] 2020―Oct―20 Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan Kun-Kuang Lee, Chih-Cheng Lai, Chien-Ming Chao, Hung-Jen Tang
234 [GO] 2020―Oct―12 Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy M. Randolph, A. Al-alola, A. Tosti
235 [GO] 2020―Oct―03 Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends Nicolas Kluger
236 [GO] 2020―Oct―03 Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, et al. (+5)
237 [GO] 2020―Oct―01 SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres-Reyes, R. Schlottmann, et al. (+4)
238 [GO] 2020―Sep―27 “Occupational dermatoses from Personal Protective Equipment during the COVID-19 pandemic in the tropics - A Review” HC Lee, CL Goh
239 [GO] 2020―Sep―26 Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men Andy Goren, Carlos Gustavo Wambier, Sabina Herrera, John McCoy, Sergio Vaño-Galván, Francesca Gioia, et al. (+9)
240 [GO] 2020―Sep―25 Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients John McCoy, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Francesca Gioia, Belen Comeche, et al. (+9)
241 [GO] 2020―Sep―24 Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19 Tetsuo Shiohara, Yoshiko Mizukawa
242 [GO] 2020―Sep―01 Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey Eda Öksüm Solak, Burcu Baran Ketencioglu, Hümeyra Aslaner, Salih Levent Çinar, Demet Kartal, Ali Ramazan Benli, Murat Borlu
243 [GO] 2020―Sep―01 Frequent hand washing and disinfection-a potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak Yukimasa Tai, Takeshi Fukumoto, Masahiro Oka, Chikako Nishigori
244 [GO] 2020―Sep―01 How the use of surgical masks during COVID-19 pandemic can induce skin effects S. Veronese, P. Bernardi, A. Sbarbati
245 [GO] 2020―Sep―01 Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine I. Abadías-Granado, A.M. Palma-Ruiz, P.A. Cerro, A.M. Morales-Callaghan, M.C. Gómez-Mateo, Y. Gilaberte, R.A. Schwartz
246 [GO] 2020―Sep―01 Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding AA Kubanov, DG Deryabin
247 [GO] 2020―Aug―31 Chilblains and COVID-19: further evidence against a causal association Marie Baeck, Caroline Peeters, Anne Herman
248 [GO] 2020―Aug―27 Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “ Killing 2 birds with one ston e” M. Saha, A. D’Cruz, N. Paul, R. Healy, D. Collins, D-A. Charles, et al. (+2)
249 [GO] 2020―Aug―27 COVID-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test Jun Hayakawa, Hiroki Takakura, Yoshiko Mizukawa, Tetsuo Shiohara
250 [GO] 2020―Aug―27 Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic Isabel Martínez-Pallás, Beatriz Aldea-Manrique, Mar Ramírez-Lluch, José Manuel Vinuesa-Hernando, Mariano Ara-Martín
251 [GO] 2020―Aug―27 Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles Iria Neri, Annalisa Patrizi, Liliana Gabrielli, Annalucia Virdi, Giulia Veronesi, Ilaria Corsini, et al. (+4)
252 [GO] 2020―Aug―13 Recommendations for skin cancer consultation and surgery during COVID-19 pandemic L. Brochez, J.F. Baurain, V. Del Marmol, A. Nikkels, V. Kruse, F. Sales, et al. (+3)
253 [GO] 2020―Aug―12 Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown F. Ricci, L. Fania, A. Paradisi, G. Di Lella, S. Pallotta, L. Sobrino, et al. (+3)
254 [GO] 2020―Aug―12 Severe COVID-19 outcomes in patients with psoriasis X.T. Lima, M.A. Cueva, E.M Lopes, M.B. Alora
255 [GO] 2020―Aug―12 Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey Nikolai Dyrberg Loft, Anne-Sofie Halling, Lars Iversen, Christian Vestergaard, Mette Deleuran, Mads Kirchheiner Rasmussen, et al. (+3)
256 [GO] 2020―Aug―03 A survey on teledermatology (td) use and doctors’ perception in times of COVID-19 Elvira Moscarella, Paola Pasquali, Elisa Cinotti, Linda Tognetti, Giuseppe Argenziano, Pietro Rubegni
257 [GO] 2020―Jul―31 Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19 Anne Herman, Marine Matthews, Margaux Mairlot, Laura Nobile, Laetiia Fameree, Luc-Marie Jacquet, Marie Baeck
258 [GO] 2020―Jul―31 Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy M Talamonti, M Galluzzo, A Chiricozzi, P Quaglino, G Fabbrocini, P Gisondi, et al. (+64)
259 [GO] 2020―Jul―17 The skin in the era of coronavirus pandemic J. Ring
260 [GO] 2020―Jul―11 STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections R. Balestri, M. Magnano, L. Rizzoli, S.D. Infusino, F. Urbani, G. Rech
261 [GO] 2020―Jul―03 Concurrent chilblains and retinal vasculitis in a child with COVID-19 Lucía Quintana-Castanedo, Marta Feito-Rodríguez, Celia Fernández-Alcalde, María Granados-Fernández, Dolores Montero-Vega, Ander Mayor-Ibarguren, Raúl de Lucas-Laguna
262 [GO] 2020―Jul―03 Dermoscopy features of COVID-19-related chilblains in children and adolescents Lourdes Navarro, David Andina, Lucero Noguera-Morel, Angela Hernández-Martín, Isabel Colmenero, Antonio Torrelo
263 [GO] 2020―Jun―28 COVID-19 and cutaneous manifestations: A systematic review Qing Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang
264 [GO] 2020―Jun―28 COVID-19 and outbreak of chilblains: are they related? C. Lesort, J. Kanitakis, A. Villani, E. Ducroux, P. Bouschon, K. Fattouh, et al. (+3)
265 [GO] 2020―Jun―28 Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain MA Pastor-Nieto, P Checa-Díaz, P González-Muñoz, A Martín-Fuentes, A Vergara-Sánchez, C Sánchez-Herreros, et al. (+8)
266 [GO] 2020―Jun―28 COVID-19 Lockdown induced acral dermatosis in children Nathalie Bodak, Christine Chiaverini, Sebastien Barbarot
267 [GO] 2020―Jun―28 Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic F Rob, J Hugo, S Tivadar, P Boháč, S Gkalpakiotis, N Vargová, et al. (+2)
268 [GO] 2020―Jun―27 Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature S. Matar, B. Oulès, P. Sohier, O. Chosidow, M. Beylot-Barry, N. Dupin, S. Aractingi
269 [GO] 2020―Jun―27 Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience Marta García-Legaz Martínez, Álvaro Martínez-Doménech, Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Felipe Partarrieu-Mejías, Javier Lorca-Spröhnle, et al. (+3)
270 [GO] 2020―Jun―27 Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection J. Rouanet, E. Lang, F. Beltzung, B. Evrard, C. Henquell, I. Joulie, M. D’Incan
271 [GO] 2020―Jun―26 Relapsing symmetric livedo reticularis in a patient with COVID-19 infection M. Verheyden, M. Grosber, J. Gutermuth, B. Velkeniers
272 [GO] 2020―Jun―25 Cutaneous manifestations of SARS-CoV-2 infection: a clinical update P Gisondi, S PIaserico, C Bordin, M Alaibac, G Girolomoni, L Naldi
273 [GO] 2020―Jun―21 Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19 Anne-Claire Fougerousse, Marc Perrussel, Pierre-André Bécherel, Edouard Begon, Valérie Pallure, Ines Zaraa, et al. (+8)
274 [GO] 2020―Jun―19 ‘’Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece’’ Authors: E Vakirlis, K Bakirtzi, I Papadimitriou, F Vrani, N Sideris, A Lallas, et al. (+2)
275 [GO] 2020―Jun―19 An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient S. Negrini, A. Guadagno, M. Greco, A. Parodi, M. Burlando
276 [GO] 2020―Jun―18 Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy P Del Giudice, D Boudoumi, B Le Guen, M Reverte, J Gutnecht, JP Lacour, et al. (+3)
277 [GO] 2020―Jun―18 Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection Maria Carmela Annunziata, Angela Patrì, Angelo Ruggiero, Adriana Di Guida, Claudia Menicanti, Vincenzo Greco, Gabriella Fabbrocini
278 [GO] 2020―Jun―16 Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19 N Martínez Campayo, JI Bugallo Sanz, I Mosquera Fajardo
279 [GO] 2020―Jun―14 Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom Sofia Hadjieconomou, Jenny Hughes, Sandeep Kamath
280 [GO] 2020―Jun―14 The red half moon nail sign: a novel manifestation of Coronavirus infection Iria Neri, Alba Guglielmo, Annalucia Virdi, Valeria Gaspari, Michela Starace, Bianca Maria Piraccini
281 [GO] 2020―Jun―14 SARS-CoV-2, skin lesions and the need of a multidisciplinary approach R. Cabrera-Hernández, E. Solano-Solares, V. Chica-Guzmán, M. Fernández-Guarino, D. Fernández-Nieto, D. Ortega-Quijano, et al. (+6)
282 [GO] 2020―Jun―13 Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown Neri Iria, Virdi Annalucia, Corsini Ilaria, Guglielmo Alba, Lazzarotto Tiziana, Gabrielli Liliana, et al. (+3)
283 [GO] 2020―Jun―13 Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization C. Bitar, M.P. Chan, P.W. Harms, D.R. Fullen, J.E. Gudjonsson, M. Eshaq, et al. (+7)
284 [GO] 2020―Jun―13 Teledermatology for acne during COVID-19: high patients’ satisfaction in spite of the emergency Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Luisa Abategiovanni, Massimiliano Scalvenzi, Andrea Tajani, et al. (+2)
285 [GO] 2020―Jun―13 Cutaneous autoimmune diseases during COVID 19 pandemic C Günther, R Aschoff, S Beissert
286 [GO] 2020―Jun―12 A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 V. Caputo, J. Schroeder, F. Rongioletti
287 [GO] 2020―Jun―12 Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology Benjamin Wen Yang Ho, Dingyuan Wang, Llewelyn Yi Chang Tan, Manish Mahadeorao Bundele, Chee Hian Tan, Joel Hua-Liang Lim
288 [GO] 2020―Jun―12 Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description J. Larrondo, R. Cabrera, M. Gosch, F. Larrondo, M. Aylwin, A. Castro
289 [GO] 2020―Jun―11 The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases C.A. Rubio-Muniz, M. Puerta-Peña, D. Falkenhain-López, J. Arroyo-Andrés, M. Agud-Dios, J.L. Rodriguez-Peralto, et al. (+2)
290 [GO] 2020―Jun―11 SARS-CoV, Mers-CoV and Covid-19:what differences from a dermatological viewpoint? Franco Rongioletti
291 [GO] 2020―Jun―08 Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? D. de Perosanz-Lobo, D. Fernandez-Nieto, P. Burgos-Blasco, G. Selda-Enriquez, I. Carretero, C. Moreno, M. Fernández-Guarino
292 [GO] 2020―Jun―05 Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like” A. Mahé, E. Birckel, C. Merklen, P. Lefèbvre, C. Hannedouche, M. Jost, L. Droy-Dupré
293 [GO] 2020―Jun―04 Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic PV Chernyshov, L Tomas-Aragones, M Augustin, A Svensson, A Bewley, F Poot, et al. (+14)
294 [GO] 2020―Jun―04 Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? AM Rosell-Díaz, A Mateos-Mayo, LM Nieto-Benito, I Balaguer-Franch, E Hernández de, A Laínez-Nuez, et al. (+2)
295 [GO] 2020―Jun―04 Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report H. Hashizume, Y. Sano, S. Furukawa, S. Imokawa
296 [GO] 2020―Jun―04 Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic Riti Bhatia, Tekumalla Sindhuja, Saurabh Bhatia, Tanvi Dev, Atula Gupta, Meenu Bajpai, Somesh Gupta
297 [GO] 2020―Jun―04 Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. A Reymundo, A Fernáldez-Bernáldez, A Reolid, B Butrón, P Fernández-Rico, P Muñoz-Hernández, et al. (+2)
298 [GO] 2020―Jun―03 No antibody response in acral cutaneous manifestations associated with COVID-19 ? Rafael Mahieu, Lila Tillard, Hélène Le Guillou-Guillemette, Emeline Vinatier, Pascale Jeannin, Anne Croué, et al. (+2)
299 [GO] 2020―Jun―03 Retiform purpura as a dermatological sign of covid-19 coagulopathy X Bosch-Amate, P Giavedoni, S Podlipnik, C Andreu-Febrer, J Sanz-Beltran, A Garcia-Herrera, et al. (+2)
300 [GO] 2020―Jun―03 Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals Nicolas Kluger
301 [GO] 2020―Jun―03 Acro-ischemia and COVID-19 infection: clinical and histopathological features J Calvão, M Relvas, A Pinho, A Brinca, J.C. Cardoso
302 [GO] 2020―Jun―03 Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice L. Sacchelli, F. Viviani, G. Orioni, P. Rucci, S. Rosa, A. Lanzoni, et al. (+2)
303 [GO] 2020―Jun―03 COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy Valeria Gaspari, Iria Neri, Cosimo Misciali, Annalisa Patrizi
304 [GO] 2020―Jun―03 Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel K. Greveling, A.C.M. Kunkeler
305 [GO] 2020―Jun―03 Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic Atul Bothra, Seujee Das, Mehak Singh, Manoj Pawar, Anshu Maheswari
306 [GO] 2020―May―31 A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, et al. (+9)
307 [GO] 2020―May―26 Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) M. Dominguez-Santas, B. Diaz-Guimaraens, P. Garcia Abellas, C. Moreno-Garcia del Real, P. Burgos-Blasco, A. Suarez-Valle
308 [GO] 2020―May―26 COVID-19 in a melanoma patient under treatment with checkpoint inhibition P. Schmidle, T. Biedermann, C. Posch
309 [GO] 2020―May―26 Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children P. Labé, A. Ly, C. Sin, M. Nasser, E. Chapelon-Fromont, P. Ben Saïd, E. Mahé
310 [GO] 2020―May―26 The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni
311 [GO] 2020―May―26 A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada
312 [GO] 2020―May―26 Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review A. Docampo-Simón, M.J. Sánchez-Pujol, G. Juan-Carpena, J.C. Palazón-Cabanes, E. Vergara-De Caso, L. Berbegal, et al. (+9)
313 [GO] 2020―May―26 Coronavirus 19 presenting with atypical Sweet's syndrome B. Taşkın, S. Vural, E. Altuğ, C. Demirkesen, E. Kocatürk, İ. Çelebi, et al. (+2)
314 [GO] 2020―May―26 Late onset of acral necrosis after SARS-CoV-2 infection resolution R. Balestri, S. Termine, G. Rech, C.R. Girardelli
315 [GO] 2020―May―22 Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19 C. Guarneri, E. Venanzi Rullo, R. Gallizzi, M. Ceccarelli, S.P. Cannavò, G. Nunnari
316 [GO] 2020―May―22 COVID-19 and its implications for Dermatology and Venereology J. Ring
317 [GO] 2020―May―22 Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report A Mayor-Ibarguren, M Feito-Rodriguez, L Quintana Castanedo, E Ruiz-Bravo, D Montero Vega, P Herranz-Pinto
318 [GO] 2020―May―22 Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China H. Long, H. Zhao, A. Chen, Z. Yao, B. Cheng, Q. Lu
319 [GO] 2020―May―20 Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic MF García-Gil, M García García, J Monte Serrano, L Prieto-Torres, M Ara-Martín
320 [GO] 2020―May―19 COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists Dina Hassan Fahmy, Heba Saed El-Amawy, Marwa Ahmed El-Samongy, Aya Ashraf Foud, Sarah Hamdy Soliman, Aya El-Kady, et al. (+9)
321 [GO] 2020―May―19 Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Andrea Agostini, et al. (+3)
322 [GO] 2020―May―19 A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema M Herrero-Moyano, TM Capusan, M Andreu-Barasoain, J Alcántara-González, M Ruano-Del Salado, ME Sánchez-Largo Uceda, et al. (+2)
323 [GO] 2020―May―19 Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions? M Goldust, A Abdelmaksoud, Z Shuang, C Xiang, AA Navarini
324 [GO] 2020―May―18 Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? C Skayem, C Cassius, M Ben Kahla, C Fiani, L Frumholtz, M Mrad, et al. (+5)
325 [GO] 2020―May―18 A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect? N. Skroza, N. Bernardini, V. Balduzzi, A. Mambrin, A. Marchesiello, S. Michelini, et al. (+5)
326 [GO] 2020―May―18 Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study Liyun Dong, Liu Yang, Yan Li, Jing Yang, Xiangjie An, Liu Yang, et al. (+8)
327 [GO] 2020―May―16 Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Maarten Vermeer Evangelia Papadavid, Julia Scaribrick, Pablo Ortiz Romero, Pietro Guaglino, Maarten Vermeer, Robert Knobler, et al. (+2)
328 [GO] 2020―May―12 Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases Mehak Singh, Manoj Pawar, Atul Bothra, Anshu Maheshwari, Vivek Dubey, Apoorv Tiwari, Awatef Kelati
329 [GO] 2020―May―09 Dermatologic Surgery Training during the COVID-19 era José Alberto García-Lozano, Adrian Cuellar-Barboza, Verónica Garza-Rodríguez, Osvaldo Vázquez-Martínez, Jorge Ocampo-Candiani
330 [GO] 2020―May―09 Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, Mar Llamas-Velasco
331 [GO] 2020―May―09 Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia Catherine Gunawan, Allen Widysanto
332 [GO] 2020―May―09 Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic V Campbell, D Middleton, J Donnelly, H Hunter
333 [GO] 2020―May―09 Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient A.G. Locatelli, E. Robustelli Test, P. Vezzoli, A. Carugno, E. Moggio, L. Consonni, et al. (+2)
334 [GO] 2020―May―09 “Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient A Sernicola, G Carnicelli, M Di Fraia, C Chello, C Furlan, R Muharremi, et al. (+2)
335 [GO] 2020―May―09 COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management Cristina Mugheddu, Laura Pizzatti, Silvia Sanna, Laura Atzori, Franco Rongioletti
336 [GO] 2020―May―09 Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman E. Robustelli Test, P. Vezzoli, A. Carugno, F. Raponi, A. Gianatti, F. Rongioletti, P. Sena
337 [GO] 2020―May―09 Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 Hicham Janah, Ali Zinebi, Jalal Elbenaye
338 [GO] 2020―May―09 SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab Francesca Caroppo, Giulia Biolo, Anna Belloni Fortina
339 [GO] 2020―May―07 Drug-induced vasculitis in a patient with COVID-19 A. Vanegas Ramirez, D. Efe, M. Fischer
340 [GO] 2020―May―07 Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs A. Conti, C. Lasagni, L. Bigi, G. Pellacani
341 [GO] 2020―May―07 Acro-ischemia in hospitalized COVID-19 patients A. Suarez-Valle, D. Fernandez-Nieto, B. Diaz-Guimaraens, M. Dominguez-Santas, I. Carretero, B. Perez-Garcia
342 [GO] 2020―May―07 Symmetric cutaneous vasculitis in COVID-19 pneumonia Laura Castelnovo, Francesca Capelli, Antonio Tamburello, Paola Maria Faggioli, Antonino Mazzone
343 [GO] 2020―May―07 SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes M Delfino, M Guida, A Patrì, L Spirito, L Gallo, G Fabbrocini
344 [GO] 2020―May―07 Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient F. Benhadou, V. Del Marmol
345 [GO] 2020―May―03 Hand disinfection in the combat against Covid-19 M Goldust, A Abdelmaksoud, AA Navarini
346 [GO] 2020―May―03 Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model Antonio Tejera-Vaquerizo, Eduardo Nagore
347 [GO] 2020―May―03 Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients Shiyao Pei, Yadong Xue, Shuang Zhao, Navarini Alexander, Goldust Mohamad, Xiang Chen, Mingzhu Yin
348 [GO] 2020―May―02 COVID-19 epidemic: Skin protection for health care workers must not be ignored Bin Zhang, Ruijie Zhai, Lin Ma
349 [GO] 2020―May―02 Histological pattern in Covid-19 induced viral rash Corrado Zengarini, Gionathan Orioni, Alessandra Cascavilla, Clara Horna Solera, Ciro Fulgaro, Cosimo Misciali, et al. (+2)
350 [GO] 2020―May―02 Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Amir Hooshang Ehsani, Maryam Nasimi, Zeinab Bigdelo
351 [GO] 2020―May―02 The use of Google trends for acral symptoms during COVID-19 outbreak in France Nicolas Kluger, Yannis Scrivener
352 [GO] 2020―May―02 Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus R. Balestri, G. Rech, C.R. Girardelli
353 [GO] 2020―May―02 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor R. Balestri, G. Rech, C.R. Girardelli
354 [GO] 2020―May―01 European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions Anna Balato, Fabio Ayala, Magnus Bruze, Marie-Noëlle Crepy, Margarida Gonçalo, Jeanne Duus Johansen, et al. (+10)
355 [GO] 2020―Apr―27 No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy A. Carugno, F. Raponi, A.G. Locatelli, P. Vezzoli, D.M. Gambini, M. Di Mercurio, et al. (+2)
356 [GO] 2020―Apr―27 Vascular skin symptoms in COVID-19: a french observational study JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, et al. (+6)
357 [GO] 2020―Apr―25 Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic M. Kasperkiewicz, E. Schmidt, J.A. Fairley, P. Joly, A.S. Payne, M.L. Yale, et al. (+2)
358 [GO] 2020―Apr―25 Skin cancer triage and management during COVID-19 pandemic Luca Tagliaferri, Alessandro Di Stefani, Giovanni Schinzari, Bruno Fionda, Ernesto Rossi, Laura Del Regno, et al. (+5)
359 [GO] 2020―Apr―24 Acral cutaneous lesions in the Time of COVID-19 S. Recalcati, T. Barbagallo, L.A. Frasin, F. Prestinari, A. Cogliardi, M.C. Provero, et al. (+3)
360 [GO] 2020―Apr―24 Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Vincenzo Piccolo, Iria Neri, Cesare Filippeschi, Teresa Oranges, Giuseppe Argenziano, Vincenzo Claudio Battarra, et al. (+9)
361 [GO] 2020―Apr―24 Cutaneous manifestation of COVID-19 in images: A case report R. Avellana Moreno, Estela Villa, V. Avellana Moreno, C. Estela Villa, Moreno Aparicio, Avellana Fontanella
362 [GO] 2020―Apr―24 Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection C. van Damme, E. Berlingin, S. Saussez, O. Accaputo
363 [GO] 2020―Apr―24 Did Whatsapp ® reveal a new cutaneous COVID-19 manifestation? TA Duong, C Velter, M Rybojad, C Comte, M Bagot, L Sulimovic, JD Bouaziz
364 [GO] 2020―Apr―24 Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies S. Garcovich, F.S Bersani, A. Chiricozzi, C. De Simone
365 [GO] 2020―Apr―24 Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome A. Tammaro, G.A.R. Adebanjo, F.R. Parisella, A. Pezzuto, J. Rello
366 [GO] 2020―Apr―24 Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports S. Ferrucci, M. Romagnuolo, L. Angileri, E. Berti, S. Tavecchio
367 [GO] 2020―Apr―24 SARS-CoV-2 infection presenting as a febrile rash F Amatore, N Macagno, M Mailhe, B Demarez, C Gaudy-Marqueste, JJ Grob, et al. (+3)
368 [GO] 2020―Apr―22 Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice P Gisondi, S Piaserico, A Conti, L Naldi
369 [GO] 2020―Apr―21 Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S M. Hedou, F. Carsuzaa, E. Chary, E. Hainaut, F. Cazenave-Roblot, M. Masson Regnault
370 [GO] 2020―Apr―17 Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic Mehdi Gheisari, Farnaz Araghi, Hamideh Moravvej, Mohammadreza Tabary, Sahar Dadkhahfar
371 [GO] 2020―Apr―17 Covid-19: Countermeasure for N95 mask-induced pressure sore ZhiQiang Yin
372 [GO] 2020―Apr―17 Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? Ambra Di Altobrando, Annalisa Patrizi, Federico Bardazzi
373 [GO] 2020―Apr―15 Viral exanthem in COVID-19, a clinical enigma with biological significance Chia-Jui Su, Chih-Hung Lee
374 [GO] 2020―Apr―15 COVID-19 and Cutaneous manifestations Rujittika Mungmungpuntipantip, Viroj Wiwanitkit
375 [GO] 2020―Apr―15 Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic C. Marasca, A. Ruggiero, M.C. Annunziata, G. Fabbrocini, M. Megna
376 [GO] 2020―Apr―15 Urticarial eruption in COVID-19 infection D. Henry, M. Ackerman, E. Sancelme, A. Finon, E. Esteve
377 [GO] 2020―Apr―15 Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies D Fernandez-Nieto, D Ortega-Quijano, G Segurado-Miravalles, C Pindado-Ortega, M Prieto-Barrios, J Jimenez-Cauhe
378 [GO] 2020―Apr―15 Cutaneous manifestations in COVID-19: a new contribution Andrea Estébanez, Leticia Pérez-Santiago, Esmeralda Silva, Santiago Guillen-Climent, Alejandro García-Vázquez, M. Dolores Ramón
379 [GO] 2020―Apr―15 A distinctive skin rash associated with Coronavirus Disease 2019 ? A. Mahé, E. Birckel, S. Krieger, C. Merklen, L. Bottlaender
380 [GO] 2020―Apr―15 Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) L. Atzori, C. Mugheddu, G. Addis, S. Sanna, R. Satta, C. Ferreli, et al. (+3)
381 [GO] 2020―Apr―15 SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor F. Messina, S. Piaserico
382 [GO] 2020―Mar―29 Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! Deepak Jakhar, Ishmeet Kaur, Subuhi Kaul
383 [GO] 2020―Mar―29 European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis Andreas Wollenberg, Carsten Flohr, Dagmar Simon, Michael J Cork, Jacob P. Thyssen, Thomas Bieber, et al. (+27)
384 [GO] 2020―Mar―27 What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist’s perspective from China Hanlin Zhang, Keyun Tang, Rouyu Fang, Qiuning Sun
385 [GO] 2020―Mar―27 Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances M Reinholz, LE French
386 [GO] 2020―Mar―26 Cutaneous manifestations in COVID-19: a first perspective S. Recalcati
387 [GO] 2020―Mar―23 Dermatology staff participate in fight against Covid-19 in China Yue Zheng, Wei Lai
388 [GO] 2020―Mar―23 Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital G. Radi, F. Diotallevi, A. Campanati, A. Offidani
 [1] 

388 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.121 sec